These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26212814)

  • 1. Anti-Parkinsonian Activity of Hemantane on a Model of Hemiparkinsonian Syndrome in Rats.
    Ivanova EA; Kapitsa IG; Val'dman EA; Voronina TA
    Bull Exp Biol Med; 2015 Jul; 159(3):380-3. PubMed ID: 26212814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of hemantane in injectable dosage form on levodopa-induced dyskinesia in rats with model parkinsonian syndrome].
    Kapitsa IG; Ivanova EA; Kokshenev II; Nepoklonov AV; Val'dman EA; Voronina TA
    Eksp Klin Farmakol; 2014; 77(5):3-5. PubMed ID: 25033563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antiparkinson activity of a new adamantane derivative].
    Val'dman EA; Voronina TA; Nerobkova LN
    Eksp Klin Farmakol; 1999; 62(4):3-6. PubMed ID: 10513325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimation of the protective effect of the novel potential antiparkinsonian agent himantane against MPTP neurotoxicity].
    Val'dman EA; Nerobkova LN; Voronina TA
    Eksp Klin Farmakol; 2004; 67(1):7-10. PubMed ID: 15079899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of hemantane effects in rats on a model of early (premotor) stage of Parkinson's disease].
    Nepoklonov AV; Kapitsa IG; Ivanova EA; Voronina TA; Val'dman EA
    Eksp Klin Farmakol; 2012; 75(11):3-6. PubMed ID: 23323324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of amantadine and hemantane effects on development of levodopa-induced dyskinesia in rat model of parkinsonian syndrome].
    Kapitsa IG; Ivanova EA; Nepoklonov AV; Kokshenev II; Voronina TA; Val'dman EA
    Eksp Klin Farmakol; 2011; 74(7):9-12. PubMed ID: 21894760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The acute and subchronic effects of hemantane on [3H]-dopamine reuptake in rat striatal synaptosomes ex vivo].
    Abaimov DA; Kovalev GI
    Eksp Klin Farmakol; 2007; 70(4):11-4. PubMed ID: 18078034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.
    Lebsanft HB; Kohles T; Kovar KA; Schmidt WJ
    Synapse; 2005 Mar; 55(3):148-55. PubMed ID: 15602749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
    Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of hemantane on the generative function and gonad morphology in rats].
    Smol'nikova NM; Nemova EP; Sorokina AV; Val'dman EA; Durnev AD
    Eksp Klin Farmakol; 2004; 67(6):45-7. PubMed ID: 15707015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
    Singh A; Naidu PS; Kulkarni SK
    Indian J Exp Biol; 2003 Nov; 41(11):1264-8. PubMed ID: 15332494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the new potential anti-Parkinson agent, hymantane, on levels of monoamines and their metabolites in rat striatum (a microdialysis study)].
    Andiarzhanova EA; Val'dman EA; Kudrin VS; Raevskiĭ KS; Voronina TA
    Eksp Klin Farmakol; 2001; 64(6):13-6. PubMed ID: 11871228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of neurophysiological effects of adamantane derivatives in the experimental parkinsonism model].
    Katunina EA; Samoĭlova EV; Val'dman EA; Nerobkova LN; Voronina TA; Avakian GN
    Eksp Klin Farmakol; 2004; 67(2):16-8. PubMed ID: 15188753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice].
    Zimin IA; Logvinov IO; Antipova TA; Kovalev GI
    Eksp Klin Farmakol; 2011; 74(1):11-4. PubMed ID: 21476268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra.
    Konieczny J; Czarnecka A; Lenda T; Kamińska K; Lorenc-Koci E
    Behav Brain Res; 2014 Mar; 261():79-88. PubMed ID: 24361083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of hemantane and doxycycline on MPTP-evoked behavior violations in C57BL/6 mice].
    Kovalev GI; Salimov RM
    Eksp Klin Farmakol; 2011; 74(5):3-5. PubMed ID: 21809690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats.
    Marin C; Aguilar E; Obeso JA
    Mov Disord; 2006 May; 21(5):646-53. PubMed ID: 16437585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the novel aminoadamantane derivative A-7 on Parkinsonian syndrome induced by systemic administration of neurotoxin MPTP].
    Nerobkova LN; Val'dman EA; Voronina TA; Markina NV; Sharkova LM
    Eksp Klin Farmakol; 2000; 63(3):3-6. PubMed ID: 10934586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of antiparkinsonian drug hemantane on the level and metabolism of biogenic monoamines in brain structures of C57BL/6 mice].
    Abaimov DA; Zimin IA; Kudrin VS; Kovalev GI
    Eksp Klin Farmakol; 2009; 72(1):64-7. PubMed ID: 19334515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of himantane and amantadine effects in experimental intracerebral posttraumatic hematoma].
    Kotel'nikova SO; Nepoklonov AV; Kokshenev II; Ivanova EA; Kraĭneva VA; Val'dman EA; Garibova TL; Voronina TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):63-6. PubMed ID: 23235415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.